Home Cart Sign in  
Chemical Structure| 1211-19-4 Chemical Structure| 1211-19-4

Structure of SIRT-IN-3
CAS No.: 1211-19-4

Chemical Structure| 1211-19-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SIRT-IN-3 is an effective SIRT inhibitor with an IC50 of 17 μM for SIRT1, and selectivity is 4 times and 14 times for SIRT2 and SIRT3, respectively, making it suitable for SIRT1-mediated metabolism and aging-related research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SIRT-IN-3

CAS No. :1211-19-4
Formula : C13H12N2O
M.W : 212.25
SMILES Code : O=C(N)C1=CC=CC=C1NC2=CC=CC=C2
MDL No. :MFCD00476529
InChI Key :JKWQUMKCVDUICQ-UHFFFAOYSA-N
Pubchem ID :96455

Safety of SIRT-IN-3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SIRT-IN-3

epigenetics

Isoform Comparison

Biological Activity

Description
SIRT-IN-3 is a potent inhibitor of SIRT, with an IC50 of 17 μM for SIRT1. It exhibits approximately 4-fold and 14-fold selectivity for SIRT1 over SIRT2 and SIRT3, with IC50 values of 74 μM and 235 μM for SIRT2 and SIRT3, respectively[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.71mL

0.94mL

0.47mL

23.56mL

4.71mL

2.36mL

47.11mL

9.42mL

4.71mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories